.jpg?format=webp&width=780)
Inhibition of the immunoproteasome in castration-resistant prostate cancer (CRPC) cells or a tumor graft mouse model via LMP7 knockout or treatment with the epoxyketone inhibitor ONX 0914 prevents disease progression by inducing apoptosis. This strategy provides a promising therapeutic approach for CRPC.
Like
Save
Share